Cotización Alexion Pharmaceuticals, Inc.
Acciones
ALXN
US0153511094
Farmacéuticos
Directores | Puesto | Edad | Desde |
---|---|---|---|
Marc Dunoyer
CEO | Chief Executive Officer | 71 | - |
Sean Christie
DFI | Director of Finance/CFO | - | 01/08/21 |
Chief Tech/Sci/R&D Officer | - | 01/12/20 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+33,50 % | 701 mil M | |
+26,24 % | 571 mil M | |
+0,78 % | 381 mil M | |
+20,85 % | 334 mil M | |
+16,38 % | 319 mil M | |
+2,79 % | 210 mil M | |
+1,00 % | 210 mil M | |
-6,69 % | 201 mil M | |
-3,51 % | 157 mil M |